Radiobiological Studies of Microvascular Damage through In Vitro Models: A Methodological Perspective.

in-vitro model ionizing radiation microenvironment microvasculature organ-on-chip radiobiological models radiotherapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Mar 2021
Historique:
received: 09 02 2021
revised: 01 03 2021
accepted: 03 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

Ionizing radiation (IR) is used in radiotherapy as a treatment to destroy cancer. Such treatment also affects other tissues, resulting in the so-called normal tissue complications. Endothelial cells (ECs) composing the microvasculature have essential roles in the microenvironment's homeostasis (ME). Thus, detrimental effects induced by irradiation on ECs can influence both the tumor and healthy tissue. In-vitro models can be advantageous to study these phenomena. In this systematic review, we analyzed in-vitro models of ECs subjected to IR. We highlighted the critical issues involved in the production, irradiation, and analysis of such radiobiological in-vitro models to study microvascular endothelial cells damage. For each step, we analyzed common methodologies and critical points required to obtain a reliable model. We identified the generation of a 3D environment for model production and the inclusion of heterogeneous cell populations for a reliable ME recapitulation. Additionally, we highlighted how essential information on the irradiation scheme, crucial to correlate better observed in vitro effects to the clinical scenario, are often neglected in the analyzed studies, limiting the translation of achieved results.

Identifiants

pubmed: 33803333
pii: cancers13051182
doi: 10.3390/cancers13051182
pmc: PMC7967181
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG21479
Organisme : Swiss National Science Foundation
ID : SNF 310030_179167
Pays : Switzerland

Références

Int Immunopharmacol. 2006 Dec 5;6(12):1788-95
pubmed: 17052669
Front Oncol. 2020 Jan 17;9:1563
pubmed: 32010633
J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1443-57
pubmed: 23689827
Cell Death Dis. 2017 Aug 10;8(8):e2978
pubmed: 28796249
Int J Radiat Biol. 2006 May;82(5):309-21
pubmed: 16782648
Int J Radiat Biol. 2019 May;95(5):562-570
pubmed: 30570385
Biochem Biophys Res Commun. 2015 Aug 14;464(1):20-6
pubmed: 26047701
J Zhejiang Univ Sci B. 2020 Apr.;21(4):327-340
pubmed: 32253842
Transl Oncol. 2008 Dec;1(4):195-201
pubmed: 19043530
Cancer Res. 2007 May 15;67(10):4886-93
pubmed: 17510418
J Radiat Res. 2011;52(1):1-8
pubmed: 21187670
World J Gastroenterol. 2005 Jul 28;11(28):4439-42
pubmed: 16038050
Cancer Biother Radiopharm. 1996 Aug;11(4):251-7
pubmed: 10851545
Biosci Rep. 2020 Apr 30;40(4):
pubmed: 32285918
Front Physiol. 2019 Jul 11;10:879
pubmed: 31354524
Cancer Lett. 2011 Dec 22;312(2):209-18
pubmed: 21937165
Int J Mol Sci. 2020 Sep 05;21(18):
pubmed: 32899466
Cancer Res. 2002 Aug 1;62(15):4300-6
pubmed: 12154033
Oncotarget. 2015 Sep 29;6(29):28238-56
pubmed: 26318587
J Radiat Res. 2015 Jul;56(4):623-32
pubmed: 25840449
PLoS One. 2012;7(4):e35740
pubmed: 22563394
Cell Signal. 2011 Aug;23(8):1299-310
pubmed: 21426933
Exp Oncol. 2019 Mar;41(1):46-52
pubmed: 30932414
Regen Med. 2017 Apr;12(3):285-302
pubmed: 28318376
Nat Rev Dis Primers. 2019 Feb 21;5(1):13
pubmed: 30792503
Cancer Res. 2000 Dec 15;60(24):6958-63
pubmed: 11156396
Acta Histochem. 2003;105(3):223-30
pubmed: 13677615
Int J Cancer. 1995 Sep 15;62(6):791-6
pubmed: 7558432
Nat Cell Biol. 2016 Mar;18(3):246-54
pubmed: 26911908
Nat Protoc. 2017 May;12(5):865-880
pubmed: 28358393
Mol Cancer Ther. 2006 Nov;5(11):2659-65
pubmed: 17121912
Radiother Oncol. 2019 Oct;139:11-17
pubmed: 31253466
Oncol Rep. 2007 Sep;18(3):709-14
pubmed: 17671724
Strahlenther Onkol. 2015 Sep;191(9):742-9
pubmed: 26051282
Int J Radiat Biol. 2013 Nov;89(11):907-14
pubmed: 23718176
Radiat Res. 2016 Aug;186(2):153-61
pubmed: 27387862
Int J Radiat Biol. 2014 Apr;90(4):306-12
pubmed: 24456547
Radiat Res. 2007 Aug;168(2):193-8
pubmed: 17638405
Acta Oncol. 2017 Aug;56(8):1048-1059
pubmed: 28303745
Biochim Biophys Acta Mol Cell Res. 2020 Jun;1867(6):118678
pubmed: 32061892
Environ Toxicol Pharmacol. 2018 Jul;61:44-51
pubmed: 29852368
Radiat Res. 2014 May;181(5):464-70
pubmed: 24754562
Oncol Rep. 2016 Feb;35(2):841-50
pubmed: 26717900
Bull Exp Biol Med. 2014 Nov;158(1):127-36
pubmed: 25408523
Invest New Drugs. 2013 Oct;31(5):1107-14
pubmed: 23912257
Trends Cell Biol. 2011 Dec;21(12):745-54
pubmed: 22033488
J Radiat Res. 2010;51(5):527-33
pubmed: 20921821
Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):588-97
pubmed: 10073961
Am J Physiol Gastrointest Liver Physiol. 2010 Jun;298(6):G865-77
pubmed: 20299603
Sci Rep. 2017 Jul 10;7(1):4933
pubmed: 28694461
J Cell Physiol. 2015 May;230(5):1094-103
pubmed: 25294801
J Exp Clin Cancer Res. 2012 Apr 26;31:37
pubmed: 22538017
Radiat Res. 2008 May;169(5):495-505
pubmed: 18439041
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):933-9
pubmed: 16467108
J Endocrinol Invest. 2016 Apr;39(4):411-22
pubmed: 26335302
Int J Radiat Biol. 2017 May;93(5):470-476
pubmed: 28110593
Mutat Res. 2011 Jul 1;712(1-2):1-10
pubmed: 21392514
Clin Exp Metastasis. 1997 Jan;15(1):12-8
pubmed: 9009101
J Clin Invest. 2012 May;122(5):1786-90
pubmed: 22466649
Radiother Oncol. 2011 Jun;99(3):271-8
pubmed: 21704412
Life Sci. 2020 Mar 1;244:117342
pubmed: 31978450
PeerJ. 2017 Aug 25;5:e3627
pubmed: 28852584
Microcirculation. 2001 Oct;8(5):355-64
pubmed: 11687947
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1518-26
pubmed: 19906497
Int J Radiat Biol. 2019 Jan;95(1):23-32
pubmed: 29883248
FASEB J. 2018 Jun 13;:fj201701099
pubmed: 29897816
Blood. 1995 Dec 1;86(11):4184-93
pubmed: 7492776
Int J Radiat Biol. 2014 Jan;90(1):71-80
pubmed: 24164458
J Biol Chem. 2004 Oct 8;279(41):43352-60
pubmed: 15292252
Radiat Oncol. 2013 Nov 01;8:257
pubmed: 24180359
Cell Mol Life Sci. 2019 Feb;76(4):699-728
pubmed: 30377700
Exp Ther Med. 2018 Aug;16(2):685-694
pubmed: 30116323
Mutat Res. 2012 Jan 3;729(1-2):52-60
pubmed: 22001237
Nucleic Acids Res. 2019 Aug 22;47(14):7294-7305
pubmed: 31251810
Int J Radiat Biol. 2003 Nov;79(11):889-96
pubmed: 14698957
Cardiovasc Res. 2007 Mar 1;73(4):806-12
pubmed: 17266944
J Thromb Haemost. 2004 Nov;2(11):2020-6
pubmed: 15550034
Cancer Lett. 2020 Oct 10;490:100-110
pubmed: 32659248
Biomed Res Int. 2013;2013:408253
pubmed: 24199192
Radiat Res. 2018 Sep;190(3):298-308
pubmed: 29901427
PLoS One. 2011;6(7):e22182
pubmed: 21799791
Clin Hemorheol Microcirc. 2015;61(2):279-90
pubmed: 26519226
Stem Cell Res. 2013 Nov;11(3):1013-21
pubmed: 23939266
Cell Stem Cell. 2018 Mar 1;22(3):310-324
pubmed: 29499151
Radiother Oncol. 2012 Jun;103(3):380-7
pubmed: 22561027
Cancer Res. 2006 Feb 15;66(4):2320-7
pubmed: 16489037
J Radiat Res. 2013 Nov 1;54(6):1036-42
pubmed: 23704776
Environ Health Prev Med. 2017 Mar 24;22(1):14
pubmed: 29165102
Cancer Biol Ther. 2006 Nov;5(11):1539-45
pubmed: 17102591
PLoS One. 2013 Jul 19;8(7):e69688
pubmed: 23894523
Radiat Res. 2014 Jul;182(1):111-21
pubmed: 24960416
Med Sci Monit. 2007 May;13(5):BR107-11
pubmed: 17476188
Cytokine. 1999 Nov;11(11):831-8
pubmed: 10547270
Radiat Res. 2007 Jul;168(1):125-33
pubmed: 17722999
Br J Cancer. 2011 Nov 8;105(10):1582-92
pubmed: 21989184
Nat Biotechnol. 2014 Aug;32(8):760-72
pubmed: 25093883
Am J Pathol. 2015 Sep;185(9):2550-62
pubmed: 26185013
Int J Med Sci. 2013 May 20;10(7):870-82
pubmed: 23781133
Mol Oncol. 2020 Jul;14(7):1461-1469
pubmed: 32293084
Int J Mol Med. 2005 Jan;15(1):145-51
pubmed: 15583841
J Radiat Res. 2005 Jun;46(2):265-76
pubmed: 15988146
J Invest Dermatol. 1994 Nov;103(5):726-30
pubmed: 7963663
Radiat Res. 2012 May;177(5):594-601
pubmed: 22087741
J Radiat Res. 2006 Nov;47(3-4):245-57
pubmed: 16960336
Int J Radiat Biol. 2020 Nov;96(11):1374-1381
pubmed: 31729901
BMC Cancer. 2019 Oct 16;19(1):958
pubmed: 31619190
Zhonghua Shao Shang Za Zhi. 2004 Oct;20(5):287-91
pubmed: 15730655
Radiat Res. 2015 Apr;183(4):447-54
pubmed: 25807321
Radiat Res. 1999 Jul;152(1):14-28
pubmed: 10381837
Cancers (Basel). 2019 Feb 10;11(2):
pubmed: 30744204
Exp Cell Res. 2013 Oct 1;319(16):2409-17
pubmed: 23800466
Transplantation. 1996 Sep 27;62(6):819-27
pubmed: 8824483
Radiat Oncol. 2010 Mar 26;5:25
pubmed: 20346162
Phys Med Biol. 2014 Mar 21;59(6):R183-231
pubmed: 24584183
Biomed Res Int. 2018 Feb 12;2018:4135806
pubmed: 29619372
Microvasc Res. 2013 Mar;86:11-20
pubmed: 23220351
Cancer Res. 2008 Apr 15;68(8):2861-9
pubmed: 18413754
Int J Radiat Biol. 2013 Oct;89(10):841-50
pubmed: 23692394
Vascul Pharmacol. 2015 Jul;70:55-65
pubmed: 25869503
Radiat Oncol. 2013 Mar 20;8:66
pubmed: 23514369
Nat Protoc. 2008;3(6):1085-91
pubmed: 18546599
Microvasc Res. 2014 Jul;94:9-16
pubmed: 24788073
Radiat Res. 2016 Dec;186(6):602-613
pubmed: 27905868
FEBS Lett. 2004 May 7;565(1-3):167-70
pubmed: 15135073
Bioengineering (Basel). 2017 Jan 24;4(1):
pubmed: 28952486
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1213-8
pubmed: 18234428
Int J Hyperthermia. 1993 Jul-Aug;9(4):517-28
pubmed: 8366302
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):506-13
pubmed: 19147015
Cell Prolif. 2009 Feb;42(1):38-48
pubmed: 19143762
J Radiat Res. 2009 Sep;50(5):469-75
pubmed: 19628926
Int J Radiat Biol. 2010 Feb;86(2):145-63
pubmed: 20148700
Proteomics. 2012 Sep;12(18):2822-32
pubmed: 22833545
Nat Rev Cancer. 2015 Jul;15(7):409-25
pubmed: 26105538
Thorac Cancer. 2010 Nov;1(4):153-162
pubmed: 27755819
Radiat Res. 2004 Jun;161(6):692-702
pubmed: 15161350
Radiat Res. 2009 Feb;171(2):173-9
pubmed: 19267542
Phys Med Biol. 1999 Jan;44(1):R1-22
pubmed: 10071870
Int J Mol Sci. 2018 Apr 04;19(4):
pubmed: 29617354
Mol Cancer Ther. 2005 Aug;4(8):1137-45
pubmed: 16093429
J Radiat Res. 2012 Jul;53(4):570-80
pubmed: 22843622
Curr Eye Res. 2002 Jan;24(1):51-7
pubmed: 12187495
Radiat Res. 2007 Feb;167(2):185-93
pubmed: 17390726
Radiat Res. 2007 Jul;168(1):106-14
pubmed: 17723002
Invest New Drugs. 2013 Feb;31(1):59-65
pubmed: 22714791
Brain. 2008 Oct;131(Pt 10):2579-95
pubmed: 18689869
Blood. 1997 Mar 15;89(6):1931-8
pubmed: 9058713
Biol Pharm Bull. 2010;33(5):752-8
pubmed: 20460750
Radiat Res. 2005 May;163(5):479-87
pubmed: 15850408
Cell Commun Signal. 2019 Dec 16;17(1):165
pubmed: 31842899
Free Radic Biol Med. 2006 Mar 15;40(6):1004-16
pubmed: 16540396
Mol Cancer Ther. 2005 Nov;4(11):1717-28
pubmed: 16275993
Bone. 2013 Jan;52(1):318-25
pubmed: 23085084
Int J Radiat Biol. 2018 Jun;94(6):597-606
pubmed: 29701998
Radiat Res. 2000 Oct;154(4):375-81
pubmed: 11023600
Oncotarget. 2015 Mar 20;6(8):5804-17
pubmed: 25714020
Pharm Res. 2016 Sep;33(9):2117-25
pubmed: 27216753
Cytotherapy. 2017 Sep;19(9):1048-1059
pubmed: 28751152
Radiat Res. 2004 Jun;161(6):703-11
pubmed: 15161349
Mol Ther. 2004 Jun;9(6):818-28
pubmed: 15194048

Auteurs

Luca Possenti (L)

Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.

Laura Mecchi (L)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.

Andrea Rossoni (A)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.

Veronica Sangalli (V)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.

Simone Bersini (S)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.

Alessandro Cicchetti (A)

Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Maria Laura Costantino (ML)

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.

Christian Candrian (C)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Facoltà di Scienze Biomediche, Università della Svizzera Italiana, 6900 Lugano, Switzerland.

Chiara Arrigoni (C)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.

Tiziana Rancati (T)

Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

Matteo Moretti (M)

Regenerative Medicine Technologies Laboratory, Servizio di Ortopedia e Traumatologia, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.
Facoltà di Scienze Biomediche, Università della Svizzera Italiana, 6900 Lugano, Switzerland.
IRCCS Istituto Ortopedico Galeazzi, Cell and Tissue Engineering Laboratory, 20161 Milan, Italy.

Classifications MeSH